Noel Timothy John 4
Research Summary
AI-generated summary
UnitedHealth (UNH) CEO Noel Timothy John Receives Award
What Happened Noel Timothy John, CEO of UnitedHealth Group (UNH), received an award on 2026-03-17 of 102.329 shares recorded at $0.00 each (total reported value $0). The reported transaction type is an award/acquisition (code A); the filing indicates these are dividend equivalents tied to outstanding restricted stock units (RSUs), not an open-market purchase.
Key Details
- Transaction date: 2026-03-17; Filing date: 2026-03-19 (timely filing).
- Shares received: 102.329 at $0.00; total reported cash value $0.
- Transaction code: A (award/acquisition).
- Shares owned after transaction: Not disclosed in this Form 4.
- Footnote: F1 — These shares represent dividend equivalents paid on outstanding RSUs; the dividend equivalents follow the same vesting/forfeiture terms as the underlying RSUs.
Context This is an award of dividend-equivalent units tied to existing RSUs, not a market purchase or sale. Such awards are routine compensation-related transactions and do not necessarily indicate a change in the insider’s market view. The filing was submitted within the normal SEC Form 4 timeframe.